Global Glycyrrhetinic Acid (CAS 471-53-4) Market Study 2016-2026, by Segment (HPLC < 95%, HPLC 95%-98%, … …), by Market (Pharmaceutical, Cosmetic, … …), by Company (Fujie Pharmaceutical, QHL Pharma, … …)

SKU ID :99ST-14678838 | Published Date: 14-Nov-2019 | No. of pages: 50
Summary
Glycyrrhetinic Acid (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional Electronics & Softwarermacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
The global Glycyrrhetinic Acid (CAS 471-53-4) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):


HPLC < 95%
HPLC 95%-98%
HPLC > 98%
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Pharmaceutical
Cosmetic
Others

Company Coverage (Sales data, Main Products & Services etc.):


Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
Alchem International
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical

Major Region

Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
  • PRICE
  • $1800
    $3600
    Buy Now

Our Clients